Su1873 RESULTS FROM AN OPEN-LABEL STUDY (ECOSPOR IV) TO EVALUATE THE SAFETY AND EFFICACY OF SER-109, AN INVESTIGATIONAL ORAL MICROBIOME THERAPEUTIC, IN ADULTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION (RCDI): A SUBGROUP ANALYSIS
Gastroenterology(2023)
关键词
recurrent clostridioides difficile infection,investigational oral microbiome therapeutic,rcdi,open-label
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要